Skip to main content

Anorexia Nervosa

6
Pipeline Programs
18
Companies
20
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
2
1
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

15 companies ranked by most advanced pipeline stage

Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
2 programs
1
RisperidonePhase 41 trial
Transcranial magnetic stimulationN/A1 trial
Active Trials
NCT02535780Terminated1Est. Jun 2016
NCT00140426Completed41Est. Dec 2009
Prevail Therapeutics
2 programs
1
1
olanzapinePhase 4
OlanzapinePhase 2
Human BioSciences
Human BioSciencesWV - Martinsburg
4 programs
1
1
Hormone replacement therapyPhase 2/31 trial
Transdermal estrogenPhase 21 trial
Higher Calorie RefeedingN/A1 trial
Low-magnitude mechanical stimulation platformN/A1 trial
Active Trials
NCT02488109Completed120Est. Jun 2020
NCT01100567Completed101Est. May 2015
NCT03875378Recruiting66Est. Dec 2028
+1 more trials
Pins Medical
Pins MedicalChina - Beijing
1 program
1
Deep Brain StimulationPhase 11 trial
Active Trials
NCT02263404Unknown16Est. Dec 2018
Heidelberg Pharma
Heidelberg PharmaGermany - Ladenburg
2 programs
Drug Transport in Patients With Anorexia NervosaN/A1 trial
GlucoseN/A1 trial
Active Trials
NCT00176150Unknown
NCT03075371Completed85Est. Feb 2019
Alliance Pharmaceuticals
2 programs
Exposure Therapy + D-CycloserineN/A1 trial
Exposure Therapy for ANN/A1 trial
Active Trials
NCT00755820Completed32Est. Jan 2012
NCT01174602Completed40Est. Oct 2014
Compass Therapeutics
2 programs
PsilocybinPHASE_2
PsilocybinPHASE_2
Compass Pathways
Compass PathwaysUK - Cheshire
2 programs
PsilocybinPHASE_21 trial
PsilocybinPHASE_21 trial
Active Trials
NCT05481736Completed32Est. Nov 2024
NCT04661514Completed16Est. Jun 2022
Cognition Therapeutics
Cognition TherapeuticsPA - Pittsburgh
1 program
Cognitive Control Deprivation TaskN/A1 trial
Active Trials
NCT07274722Recruiting54Est. Apr 2026
BrainsWay
BrainsWayJerusalem, Israel
1 program
Deep Insula-coil rTMSN/A1 trial
Active Trials
NCT03144986Completed9Est. Aug 2017
Temple Therapeutics
Temple TherapeuticsNetherlands - Geleen
1 program
Family Based Therapy for young adultsN/A1 trial
Active Trials
NCT01190423Completed22Est. Apr 2016
Shield Therapeutics
Shield TherapeuticsMA - Wellesley
1 program
Multi-Family TherapyN/A1 trial
Active Trials
NCT06203418Active Not Recruiting200Est. Dec 2026
Purdue Pharma
Purdue PharmaCT - Stamford
1 program
Smart-Treatment for Anorexia Nervosa RecoveryN/A1 trial
Active Trials
NCT05190926Unknown90Est. Jun 2024
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Transcranial Magnetic TreatmentN/A1 trial
Active Trials
NCT04846517Not Yet Recruiting45Est. Jan 2030
Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
SOMATROPINE* : Norditropine® simplexx®PHASE_2_31 trial
Active Trials
NCT01626833Completed15Est. Mar 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Colorado TherapeuticsRisperidone
Novo NordiskSOMATROPINE* : Norditropine® simplexx®
Human BioSciencesHormone replacement therapy
Compass PathwaysPsilocybin
Compass PathwaysPsilocybin
Human BioSciencesTransdermal estrogen
Pins MedicalDeep Brain Stimulation
Angeles TherapeuticsTranscranial Magnetic Treatment
Cognition TherapeuticsCognitive Control Deprivation Task
Purdue PharmaSmart-Treatment for Anorexia Nervosa Recovery
Shield TherapeuticsMulti-Family Therapy
Human BioSciencesHigher Calorie Refeeding
Colorado TherapeuticsTranscranial magnetic stimulation
Heidelberg PharmaGlucose
BrainsWayDeep Insula-coil rTMS

Showing 15 of 19 trials with date data

Clinical Trials (20)

Total enrollment: 1,065 patients across 20 trials

NCT00140426Colorado TherapeuticsRisperidone

A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa

Start: Aug 2004Est. completion: Dec 200941 patients
Phase 4Completed
NCT01626833Novo NordiskSOMATROPINE* : Norditropine® simplexx®

Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeutic Trial of Growth Hormone

Start: Mar 2013Est. completion: Mar 202115 patients
Phase 2/3Completed
NCT00310791Human BioSciencesHormone replacement therapy

Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa

Start: Apr 2004Est. completion: Dec 201080 patients
Phase 2/3Completed
NCT05481736Compass PathwaysPsilocybin

Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study

Start: Oct 2022Est. completion: Nov 202432 patients
Phase 2Completed
NCT04661514Compass PathwaysPsilocybin

Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy

Start: May 2021Est. completion: Jun 202216 patients
Phase 2Completed
NCT03875378Human BioSciencesTransdermal estrogen

Transdermal Estrogen in Women With Anorexia Nervosa

Start: Aug 2020Est. completion: Dec 202866 patients
Phase 2Recruiting
NCT02263404Pins MedicalDeep Brain Stimulation

PINS Stimulator System to Treat Severe Anorexia Nervosa

Start: Dec 2016Est. completion: Dec 201816 patients
Phase 1Unknown
NCT00176150Heidelberg PharmaDrug Transport in Patients With Anorexia Nervosa

Drug Transport in Patients With Anorexia Nervosa

N/AUnknown
NCT04846517Angeles TherapeuticsTranscranial Magnetic Treatment

rTMS for Aneroxia Nervosa in Youth

Start: Jan 2027Est. completion: Jan 203045 patients
N/ANot Yet Recruiting
NCT07274722Cognition TherapeuticsCognitive Control Deprivation Task

Influence of Control Deprivation on the Use of the Analytical Cognitive Style in Anorexic Subjects

Start: Apr 2024Est. completion: Apr 202654 patients
N/ARecruiting
NCT05190926Purdue PharmaSmart-Treatment for Anorexia Nervosa Recovery

Smart Technology for Anorexia Nervosa Recovery

Start: May 2023Est. completion: Jun 202490 patients
N/AUnknown
NCT06203418Shield TherapeuticsMulti-Family Therapy

Investigation of Multi-Family Therapy for Anorexia Nervosa

Start: May 2020Est. completion: Dec 2026200 patients
N/AActive Not Recruiting
NCT02488109Human BioSciencesHigher Calorie Refeeding

Study of Refeeding to Optimize iNpatient Gains

Start: Feb 2016Est. completion: Jun 2020120 patients
N/ACompleted
NCT02535780Colorado TherapeuticsTranscranial magnetic stimulation

Transcranial Treatments in Eating Disorders

Start: Aug 2015Est. completion: Jun 20161 patients
N/ATerminated
NCT03075371Heidelberg PharmaGlucose

Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa

Start: Sep 2014Est. completion: Feb 201985 patients
N/ACompleted
NCT03144986BrainsWayDeep Insula-coil rTMS

Insula-coil Deep TMS for Treatment Resistant Anorexia Nervosa

Start: Sep 2012Est. completion: Aug 20179 patients
N/ACompleted
NCT01190423Temple TherapeuticsFamily Based Therapy for young adults

Treatment for Young Adults With Anorexia Nervosa

Start: Jul 2010Est. completion: Apr 201622 patients
N/ACompleted
NCT01174602Alliance PharmaceuticalsExposure Therapy for AN

Inpatient Exposure Therapy and Response Prevention & Cognitive Remediation Therapy for Anorexia Nervosa

Start: Nov 2009Est. completion: Oct 201440 patients
N/ACompleted
NCT01100567Human BioSciencesLow-magnitude mechanical stimulation platform

Effect Of Biomechanical Stimulation On Skeletal Health In Adolescent And Young Women With Anorexia Nervosa

Start: Apr 2009Est. completion: May 2015101 patients
N/ACompleted
NCT00755820Alliance PharmaceuticalsExposure Therapy + D-Cycloserine

Food Exposure Therapy in Anorexia Nervosa

Start: Jan 2008Est. completion: Jan 201232 patients
N/ACompleted

Related Jobs

National Sales Director (East)

Compass PathwaysCompass Pathways
United States
4d ago
$230K - $280K/yr

Associate Director, Commercial Forecasting

Compass PathwaysCompass Pathways
New York, United States
6d ago
$160K - $210K/yr

Regional Sales Director (Mid-Atlantic)

Compass PathwaysCompass Pathways
Washington DC, United States
1w ago
$180K - $230K/yr

Regional Sales Director (Texas)

Compass PathwaysCompass Pathways
United States
1w ago
$180K - $230K/yr

Regional Sales Director (Southern California)

Compass PathwaysCompass Pathways
United States
1w ago
$180K - $230K/yr

Regional Sales Director (Pacific Northwest)

Compass PathwaysCompass Pathways
San Francisco, United States
1w ago
$180K - $230K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 1,065 patients
18 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.